Title: Acridine derivatives
Application Number: 92109524 Application Date: 1992.07.10
Publication Number: 1081181 Publication Date: 1994.01.26
Approval Pub. Date: Granted Pub. Date: 1999.03.10
International Classifi-cation: A61K31/44,C07D219/06,C07D401/12
Applicant(s) Name: Laboratories Glaxo S.A. Address:
Inventor(s) Name: Bernard Andre Dumaitre
Attorney & Agent: LUO CAIXI
Abstract:
     Compound with general formula described in specification, its salt and solution are disclosed. The said compound can make cancer cells resisting the action of several pharmaceuticals sensitive to chemicotherapy pharmaceuticals, so that it may be used for curing cancers, esp for raising the effect of other antineoplastics.
Time: 11